Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug … – BioSpace,

… Drug Candidate CB03 in First-in-Human Phase I Clinical Trial – read … “CB03 is the first drug candidate of Zhimeng to enter clinic trials in …, … Drug Candidate CB03 in First-in-Human Phase I Clinical Trial – read … “CB03 is the first drug candidate of Zhimeng to enter clinic trials in …, Read More

Scroll to Top